Medical News

RSS

Inovio Biomedical achieves 75% complete response rate in preclinical testing of DNA-based cancer vaccine using its electroporation DNA delivery system

Inovio Biomedical Corporation announced today that it achieved positive results from its proprietary research and development program for DNA-based cancer vaccines delivered using the company's electroporation-based DNA delivery technology.

15 Sep 2008

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.

15 Sep 2008

Gender differences in experience of rheumatism

Rheumatoid arthritis is often a more painful experience for women than it is for men, even though the visible symptoms are the same.

15 Sep 2008

New cannabis-like drugs could block pain without affecting brain

A new type of drug could alleviate pain in a similar way to cannabis without affecting the brain, according to a new study published in the journal Pain on Monday 15 September.

15 Sep 2008

Keppra XR approved in the U.S. for partial onset seizures

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra XR (levetiracetam extended-release tablets) for use as an add-on to other antiepileptic treatments for people with partial onset seizures who are 16 years of age and older. Keppra XR is expected to be available in U.S. pharmacies at the end of September 2008.

15 Sep 2008

30 years on from Alma-Ata and the pendulum is swinging back to primary health care

Thirty years on from the signing of the historic Alma-Ata declaration, the famous rallying call to the global health community, the concept of Primary Health Care, which lay at its heart, is back on the global agenda.

15 Sep 2008

'Dodgy dossier' partly to blame for failure of war against malaria in the tropics

The war against malaria in tropical countries was fought and lost in the 20th Century on the basis of faulty intelligence, a 'dodgy dossier' which argued that the same methods used to tackle the disease in temperate countries would also work in the tropics.

15 Sep 2008

One million pounds to improve access to physiotherapy

Providing timely access to physiotherapy is a long-standing problem for the NHS, with more than 4 million new referrals each year and waiting times of several months in many areas. A Bristol-led study to improve access has been given £1.06 million by the Medical Research Council (MRC).

15 Sep 2008

A good death: Challenging law and medical ethics

Dr Rodney Syme, author of A Good Death: An argument for voluntary euthanasia, is the keynote speaker at the Sydney Law School's Health Governance, Law and Ethics Oration on Thursday 18 September.

15 Sep 2008

Speaking on a phone while driving puts drivers at significantly greater risk of collision

The Ontario Medical Association (OMA) has released findings about the significant impact that cellphone use has on driving safety. The research clearly shows that speaking on a phone while driving puts drivers at significantly greater risk of collision. Ontario's doctors want the provincial government to take action to protect the lives of all drivers and passengers.

14 Sep 2008

Study shows high gum disease rates in rural Appalachia

Research on 445 families centered in two Pennsylvania towns and two West Virginia counties shows that 80 percent of adults suffer from more severe forms of periodontal disease, according to Richard Crout, D.M.D., Ph.D., an expert on gum disease and associate dean for research in the West Virginia University School of Dentistry.

14 Sep 2008

Scientists discover common variants in the human genome conferring risk of bladder cancer

Scientists at deCODE genetics and colleagues at Radboud University Medical Center in the Netherlands today report the discovery of two common single-letter variants in the human genome (SNPs) that confer increased risk of urinary bladder cancer.

14 Sep 2008

Neuroscientists discover a critical early step of memory formation

Researchers at the Johns Hopkins University School of Medicine report in the July issue of Neuron how nerve cells in the brain ensure that Arc, a protein critical for memory formation, is made instantly after nerve stimulation. Paradoxically, its manufacture involves two other proteins - including one linked to mental retardation - that typically prevent proteins from being made.

14 Sep 2008

Domainex has core intellectual property rights granted for Europe

Domainex Ltd (Domainex), an innovative biopharmaceutical company, today announced the grant of European Patent No.1442134 for its Combinatorial Domain Hunting (CDH) Technology.

From Domainex 14 Sep 2008

Key component of chronic obstructive pulmonary disease identified

For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans.

14 Sep 2008

Surveillance mammography after treatment for primary breast cancer

The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has commissioned a new study to identify the most effective and efficient surveillance methods for women who have received treatment for primary breast cancer.

14 Sep 2008

Anti-inflammatory drugs may mask prostate cancer marker

Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications.

14 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.

14 Sep 2008

FDA issues warning on milk-based infant formula manufactured in China

In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) is issuing a Health Information Advisory.

14 Sep 2008